RCUS Arcus Biosciences, Inc.
High-Growth Software
F 30.0 / 100 pillar composite

AlphaQuality composite grade, weighted for high-growth software businesses.

⚠ 4 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a high-growth software business.

Grade overrides the 30.0 pillar composite — hard gates always win.

Profitability

Weight: 15%
F 0
  • 5yr Avg ROIC -29.9%
  • Operating Margin Trend -21.87 pp/yr

Capital Efficiency

Weight: 15%
F 0
  • 5yr Avg ROE -43.0%
  • 5yr Share-Count CAGR 14.4%

Growth Quality

Weight: 35%
A 88
  • 5yr Revenue CAGR 25.9%
  • Revenue-Growth Years (5) 3/5

Cash Generation

Weight: 20%
F 0
  • 5yr FCF Margin -46.8%
  • 5yr FCF/NI Conversion -5.33x

Balance Sheet

Weight: 10%
F 15
  • Net Debt / EBITDA 10.00x
  • Interest Coverage (EBIT/Int) -43.12x
  • Altman Z-Score 2.55

Stability

Weight: 5%
D- 27
  • Negative-Revenue Years (5) 2/5
  • Piotroski F-Score 0

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Dumping

1 of 2 gurus held; 1 trimmed; 1 full exit.

Holders
1 -1
Avg Δ position
-62.8%
New buys
0
Full exits
1
As of Q2 2026